Immunara

Immunai

Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.

Cellular Intelligence

This company develops artificial intelligence foundation models to predict cell signaling and design cell therapies for pharmaceutical companies and clinical researchers.

Graph Therapeutics

This company develops artificial intelligence technology to create targeted therapies and biomarkers for patients with immune-mediated diseases.

Anto Biosciences

This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.

Synteny

This company develops AI-based bioinformatic solutions and programmable protein therapeutics to help pharmaceutical and biotechnology firms discover treatments for immune-driven diseases.

CellType

This company develops artificial intelligence agents and biological foundation models to simulate human biology for pharmaceutical and biotechnology drug discovery teams.

Khumbu

This company develops artificial intelligence models for molecular biology and protein-ligand interactions to accelerate drug discovery for the pharmaceutical industry.

Alp Bio

This company develops a hybrid platform combining human immune organoids and artificial intelligence to assess immunogenicity risks for biotechnology and pharmaceutical drug developers.